Replies to post #649529 on NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

You can multiply it by 100, but it ain’t happening in real world with this management. They will sell large number of C shares at under a dollar and throw the existing retail shareholders under the bus. Not the first time they will do that, but wait and watch. If it was within them they would have already done this massive dilution, but no investor wants to risk such a significant amount without getting solid confirmation on regulatory status.

They are also very good at moving the goal posts. Once MAA is submitted, acceptance of the application will be hyped and once that is done the expectations will be built around MHRA approvals….when nothing happens at that point in the second half of next year then the talks will move to FDA while the share price continues to languish under a dollar. We have a rich history of that with this management!

[aesop1]

Why would a large investment firm invest here. Are you kidding me? Can they even submit an application 3 plus years in since data lock and can't even meet their submission deadlines 1x and about to be 2x which is already horrendously late even when they do submit. The CEO enriches herself at the expense of funding 2 CDMOs and gets nailed with related party transactions by the SEC which they settled monetarily. They can only operate in syncronous mode, aka doing one thing at a time (TLD - Journal - Advent Cert - MHRA). And current stuck in mud operation right now is MHRA submission. The next stuck in mud operation is to wait for MHRA and then MHRA RFI Response to get to MHRA Acceptance. This is how bad this company operates. Oh and BTW they have no operating capital.

GTFOOH with that pump garbage.